| Title | Journal of health management and public health = Zdravotnícky manažment a verejné zdravotníctvo
|
|---|
| Year, No. | Vol. 4, no. 2, rok 1999
|
|---|
| ISSN | 1335-1885
|
|---|
| Collective Record/Entry | Journal of health management and public health
|
|---|
| Journal of health management and public health
|
|---|
| Language | ---
|
|---|
| Copy count | 1, currently available 0, at library only 1
|
|---|
| Database | PERIODIKÁ - Prijaté čísla
|
|---|
| Content | Improvement of quality of primary care / / Satya P. Chattopadhyay
|
|---|
| The role of nursing management in developing standards of patient care and measuring clinical outcomes / / Mary Jane S. Hanson
|
|---|
| Ethical issues in clinical research and randomized trials: how to organize an ethically acceptable comparative study on drug efficacy / / Harold W. Baille
|
|---|
| Successful publishing of scientific papers in scholarly journals / / Satya P. Chattopadhyay
|
|---|
| Fundraising clinical research / / Allen C. Minor, Kim Stager
|
|---|
| The role of the nurse in clinical research: a comparison of USA versus european models and experiences / / Mary Jane S. Hanson
|
|---|
| Financing primary care / / Allen C. Minor, Kim Stager
|
|---|
| International student exchange program: a collaborative effort among Trnava University, the University of Scranton and allied services / / Miriam Stankovska
|
|---|
| Instructing an oncological patient / / M. Pichňa, M. Šmíd, J. Bérešová
|
|---|
| Measuring insurance plan performance in quality patient care / / Michael M. Costello
|
|---|
| Ethical considerations in developing new models and systems of primary care / / Harold W. Baille
|
|---|
| Reasons for greater legal protection of the human life. Why is it necessary to protect society from abortion? / / M. Šmíd ... [et al.]
|
|---|
| Meeting of the kinds : letter to the editor / / Robert Babela, Michael Costa
|
|---|
| Performance improvement in primary care: quality indicators and clinical pathways / / Alice L. O'Neill
|
|---|
| Legal protection for patients who are subjects in phase I and phase II clinical trials / / Michael M. Costello
|
|---|
